Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa
ClinicoEconomics and Outcomes Research · 2026-04 · Volume 18 · 1-15
DOI: 10.2147/ceor.s571305 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-04. Verfasst von Dejan Milentijevic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson Innovative Medicine, Titusville, NJ, USA. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Johnson & Johnson Innovative Medicine, Titusville, NJ, USA.
- Milliman, Inc., New York, NY, USA.
Zitieren
APA
Milentijevic, D., Ferro, C., Rosenblum, S., & Dieguez, G. (2026). Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa. ClinicoEconomics and Outcomes Research, Volume 18, 1-15. https://doi.org/10.2147/ceor.s571305
Vancouver
Milentijevic D, Ferro C, Rosenblum S, Dieguez G. Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-15. doi:10.2147/ceor.s571305
BibTeX
@article{Milentijevic2026,
author = {Milentijevic, Dejan and Ferro, Christine and Rosenblum, Sara and Dieguez, Gabriela},
title = {Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa},
journal = {ClinicoEconomics and Outcomes Research},
year = {2026},
volume = {Volume 18},
pages = {1--15},
doi = {10.2147/ceor.s571305}
}
EUVIMED